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Fatigue in primary Sjögren’s syndrome
P J Barendregt, M R M Visser, E M A Smets, J H M Tulen, A H van den Meiracker,
F Boomsma, H M Markusse
Abstract
Objective—To assess fatigue in relation to
depression, blood pressure, and plasma
catecholamines in patients with primary
Sjögren’s syndrome (SS), in comparison
with healthy controls and patients with
rheumatoid arthritis.
Methods—For the assessment of fatigue
the Multidimensional Fatigue Inventory
(MFI) was used, a 20 item questionnaire,
covering the following dimensions: gen-
eral fatigue, physical fatigue, mental fa-
tigue, reduced motivation, and reduced
activity. Furthermore, the Zung depres-
sion scale was used to quantify aspects of
depression. Forty nine female primary SS
patients, 44 female patients with rheuma-
toid arthritis (RA), and 32 healthy women
filled in both questionnaires. In addition,
supine values of blood pressure and
plasma catecholamines were measured in
the patients with primary SS.
Results—Primary SS patients were more
fatigued compared with the healthy con-
trols on all the five dimensions of the MFI.
When the analyses were repeated using
depression as a covariate, group diVer-
ences disappeared for the dimensions of
reduced motivation and mental fatigue. In
the primary SS patients, significant posi-
tive correlations between depression and
the dimensions of reduced motivation and
mental fatigue were found. Comparing
patients with primary SS with those with
RA, using depression as covariate, no sta-
tistically significant diVerences were
found between these groups. No relation
between fatigue and blood pressure was
found, but a negative correlation was
observed between the general fatigue sub-
scale of the MFI and plasma noradrena-
line.
Conclusion—Patients with primary SS
report more fatigue than healthy controls
on all the dimensions of the MFI and when
controlling for depression significant dif-
ferences remain on the dimensions of
general fatigue, physical fatigue, and re-
duced activity. The negative correlations
between levels of noradrenaline and gen-
eral fatigue in patients with primary SS
may imply the involvement of the auto-
nomic nervous system in chronic fatigue.
(Ann Rheum Dis 1998;57:291–295)
Fatigue is the enduring, subjective sensation of
generalised tiredness or exhaustion.1 Whereas
occasional fatigue is a part of the experiences of
every day life, constant or frequent fatigue is
not.
Chronic fatigue in rheumatoid arthritis (RA)
patients is a serious problem, because it
contributes to work disability, personal injury,
inability to participate in a rehabilitation
programme, and strained relationships.2
Most patients with rheumatic diseases com-
plain of chronic fatigue3 and most studies con-
cerning fatigue in rheumatic diseases report
that disease activity, sleep disturbances, depres-
sion, and increased physical eVort most
strongly contribute to complaints of fatigue.4
Primary Sjögren’s syndrome (SS) is a
systemic autoimmune disease characterised by
lymphocytic infiltration of endocrine glands.
Keratoconjunctivitis sicca and xerostomia gen-
erally are considered to be dominant features,
but patients may suVer from many extraglan-
dular features such as arthritis, exanthema,
respiratory tract involvement, and neuropsy-
chiatric symptoms.5 In contrast with other
autoimmune diseases such as RA, in primary
SS valid parameters for disease activity are
lacking. In primary SS, fatigue is an important,
and sometimes the most disabling, symptom of
the disease,6 but studies on fatigue and its
characteristics in these patients are rare.
It has recently been suggested that chronic
fatigue may be related to low blood pressure
and to abnormalities of the autonomic nervous
system.7–10 As the presence of autonomic
dysfunction has been reported in rheumatic
diseases including RA,11 systemic lupus ery-
thematosus (SLE),12 systemic sclerosis,13 and
primary SS,14 it may be hypothesised that there
is a link between autonomic dysfunction and
fatigue in these diseases.
The aim of this study was to assess the level
of fatigue in primary SS patients and its
association with depression, disease activity,
and autonomic function. Therefore character-
istics of fatigue in primary SS were compared
with those in patients with RA with diVerent
levels of disease activity and to the fatigue
levels in normal subjects.
Methods
PATIENTS
Three groups of women were studied:
Group 1: 49 consecutive women with pri-
mary SS according to the European Criteria,15
aged 20–85 years (median 54), with a disease
duration of 1–30 years (median 5), from the
outpatients clinic of the Department of Rheu-
matology, Dr Daniel den Hoed Clinic, Rotter-
dam. All patients had more than one focus of>
50 mononuclear cells per 4 mm2 salivary gland
tissue of the lower lip16 (30 positive out of 34
tested) and/or an abnormal parotic gland
sialography17 (37 positive out of 45 tested), as
well as at least one of the following serological
abnormalities: antinuclear antibodies (ANA,
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35 out of 49 positive), rheumatoid factor (RF,
24 out of 46 positive), or antibodies to SS-A
(32 out of 49 positive) or SS-B (17 out of 49
positive) antigens. The median and range of
erythrocyte sedimentation rate, â-2 micro-
globulin, and haemoglobin in this patient
group were 29 (11–110) mm 1st h, 1.8
(1.1–4.8) mg/l, and 7.6 (5.5–9.3) mmol/l
respectively.
Group 2: 44 consecutive women with sero-
positive RA according to the ARA criteria,18
aged 24–92 years (median 65), with a disease
duration of 2–54 years (median 14), derived
from the same outpatient clinic.
Group 3: 32 healthy women, aged 26–82
years (median 57), who were relatives of
patients or hospital employees, served as
controls. None of the women asked to partici-
pate in the study refused.
Women were excluded from study participa-
tion when they suVered from neurological dis-
ease, amyloidosis, renal failure, diabetes melli-
tus or other diseases known to interfere with
the autonomic nervous system or receiving
drug treatment interfering with the autonomic
nervous system including diuretics, anti-
arrhythmics, neuroleptics, anti-epileptic, and
anti-depressive drugs.
The study was approved by the Medical
Ethical Committees of the Dr Daniel den
Hoed Clinic and the University Hospital
Rotterdam-Dijkzigt.
QUESTIONNAIRES
At intake, all women completed the Multi-
dimensional Fatigue Inventory (MFI) and the
Zung depression scale. The MFI is a 20 item
self report scale, designed to objectivate fatigue
and covering the following dimensions: general
fatigue, physical fatigue, mental fatigue, re-
duced motivation, and reduced activity. Each
scale consists of two items indicating fatigue
and two items contraindicating fatigue, to limit
possible influence of answering tendencies. A
higher score indicates a higher level of fatigue
(range 4–20). The answers given should reflect
feelings of the subjects over the past few days.
The scale was previously tested and validated
in populations of chronic fatigued patients,
cancer patients, soldiers, and psychology
students.19 In figure 1 examples of items of the
diVerent scales are presented.
The Zung-Self Rating Depression Scale was
used as a quantitative measure of depressive
symptomatology. The scale is also self adminis-
tered and contains 20 items covering aVective,
psychological, and somatic features of
depression.20 Items concerning fatigue were
excluded from statistical analysis.
CLINICAL INVESTIGATION
Blood pressure measurements
In the primary SS patients blood pressure
measurements were done by means of continu-
ous registration of arterial blood pressure
Figure 1 Example of the Multidimensional Fatigue Inventory.
Instructions:
By means of the following statements we would like to get an idea of how you have been feeling
lately. There is, for example, the statement:
If you think that this is entirely true, that indeed you have been feeling relaxed lately, please place
an X in the extreme left box; like this:
The more you disagree with the statement, the more you can place an X in the direction of "no, that
is not true". Please, do not miss out a statement and place one X next to each statement.
1. I feel fit
2. Physically I feel only able to do a little
3. I feel very active
4. I feel like doing all sorts of nice things
5. I feel tired
no, that is not trueyes, that is true
"I feel relaxed"
no, that is
not true
yes, that is
true
no, that is
not true
yes, that is
true
no, that is
not true
yes, that is
true
no, that is
not true
yes, that is
true
no, that is
not true
yes, that is
true
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(brachial or radial artery) during 15 minutes of
supine rest.
Plasma catecholamines
Blood samples (10 ml per sample) were
obtained after 10 minutes in supine position for
the determination of plasma catecholamine
concentrations (noradrenaline, adrenaline).
Blood was collected in chilled heparinised
polystyrene tubes containing glutathione (1.2
mg/ml). The tubes were centrifuged within 30
minutes (4°C, 10 minutes, 3000 × g) and the
plasma was stored at −700 C. Concentrations
of noradrenaline and adrenaline were meas-
ured by high performance liquid chromatogra-
phy with fluorometric detection as described
previously.21
Disease activity
In patients with primary SS, erythrocyte
sedimentation rate (ESR), haemoglobin (Hb),
and â2-microglobulin (â2-m) in serum were
used as parameters of disease activity. The level
of disease activity of the patients with RA was
determined by means of the Disease Activity
Score (DAS) (range from 0–8), which incorpo-
rates the Ritchie articular index, the number of
swollen joints, and the ESR.22
STATISTICAL ANALYSIS
One way analyses of variance were performed
with group as a between subject factor
(primary SS v controls; RA v controls; primary
SS v RA) on the diVerent scales of fatigue. The
same analyses were performed again using
depression as covariate. Pearson’s correlation
coeYcients were computed between the scores
of the subscales of the MFI and the Zung scale
and between the scores of the subscales of the
MFI and Hb, â2-m, ESR, age, disease
duration, blood pressure level, and concentra-
tions of plasma noradrenaline and adrenaline
respectively. A p value of <0.05 was considered
to indicate significance.
Results
Table 1 shows the scores of the MFI and the
Zung depression scale. Table 2 gives the results
of blood pressure, heart rate, and plasma
catecholamine measurements in the primary
SS patients.
For each scale of the MFI, the patients with
primary SS had significantly higher scores
compared with the healthy controls (p<
0.001).
To correct for the influence of depressive
symptoms, analyses were performed control-
ling for depression by including it as covariate.
By so doing, the statistical significance of the
group diVerence disappeared for the dimen-
sions of reduced motivation and mental
fatigue, but not for general fatigue, physical
fatigue, and reduced activity (table 1). If clini-
cal significant fatigue is defined as the mean (2
SD) of healthy controls, 57% of the primary SS
patients suVered from fatigue.
The primary SS patients showed also signifi-
cantly higher scores on the Zung depression
scale compared with the healthy controls (table
1).
In the patients with primary SS, significant
positive correlations were found between the
scores of the MFI and the Zung depression
scale, varying from 0.41 (p< 0.01) for the
dimension of general fatigue to 0.49 (p<0.001)
and 0.61 (p< 0.001) for the dimensions of
reduced motivation and mental fatigue respec-
tively.
No significant correlations were found in the
patients with primary SS between the fatigue
scores and the Hb, â2-m, and ESR (used as
measures of the disease activity), age, and dis-
ease duration respectively, nor with systolic
blood pressure measurements or heart rate in
supine position. A significant negative correla-
tion was found between the concentrations of
plasma noradrenaline in the supine position (r
= −0.38, p< 0.05) and the subscale general
fatigue, but no significant correlations were
found between the plasma concentrations of
adrenaline and general fatigue.
When comparing patients with primary SS
with patients with RA, the first group had
higher scores on the dimensions of general
fatigue (p=0.005) and mental fatigue (p=0.05)
compared with the second group. When the
analyses were performed by controlling for
depression, no significant diVerences remained
between these patient groups (table 1). No sig-
nificant diVerences in depression were found
between the two patient groups.
For each scale of the MFI, patients with RA
showed significantly higher scores compared
with the healthy controls (general fatigue,
physical fatigue, and reduced activity: p<
0.001, reduced motivation: p< 0.005, mental
fatigue: p<0.05).
When the analyses were performed by
controlling for depression by including it as
covariate, the statistical significance disap-
peared for the dimensions of reduced motiva-
tion and mental fatigue, but not for general
fatigue, physical fatigue, and reduced activity
Table 1 Scores of the Multidimensional Fatigue Inventory and the Zung Depression Scale
in patients with primary Sjögren’s syndrome, patients with rheumatoid arthritis, and
healthy controls
Primary Sjögren
syndrome (n=49)
Rheumatoid arthritis
(n=44) Controls (n=32)
General fatigue 15.57 (4.3)* 12.93 (4.5)‡ 8.16 (3.8)
Physical fatigue 14.06 (4.4)* 12.45 (5.0)§ 6.47 (3.2)
Reduced activity 11.32 (4.6)† 11.48 (4.7)‡ 6.72 (3.0)
Reduced motivation 9.96 (4.0) 9.27 (4.1) 6.66 (2.4)
Mental fatigue 10.31 (5.4) 8.34 (4.0) 6.53 (3.0)
Zung score 61 (18)* 55 (19)§ 34 (12)
All values represent mean (SD) (depression used as a covariate). Primary SS v controls: *p< 0.001
†p< 0.05. Primary SS v rheumatoid arthritis: no statistically significant diVerences. Rheumatoid
arthritis v controls: ‡p< 0.001, §p< 0.001
Table 2 Results of blood pressure, heart rate, and plasma
catecholamine measurements in 49 patients with primary
Sjögren syndrome
Supine position
Systolic blood pressure 130 (104–175)
Diastolic blood pressure 65 (49–85)
Heart rate 70 (52–101)
Adrenaline 32 (5–115)
Noradrenaline 151 (28–470)
All values represent median and (range). Blood pressure in
mm Hg. Adrenaline and noradrenaline in pg/ml.
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(table 1). The RA patients showed also signifi-
cantly higher scores on the Zung depression
scale compared with the healthy controls (table
1). For all the scales of the MFI, a correlation
was found with the Zung depression scale,
varying from 0.58 (general fatigue, p<0.001) to
0.74 (reduced motivation, p<0.001).
In the patients with RA the DAS scores were
varying between 1 and 6.2 (mean 3.1), indicat-
ing that RA patients with both quiet and active
RA were included. Significant positive correla-
tions were found between the DAS score and
general fatigue (r=0.43, p<0.05), physical
fatigue (r=0.47, p<0.01), and reduced activity
(r=0.42, p<0.05), respectively. No significant
correlations were observed between the DAS
score and reduced motivation and mental
fatigue, nor between the DAS score and the
results of the Zung scale.
Discussion
Considering our definition of fatigue, more
than 50% of the primary SS patients in this
study suVered from fatigue, indicating the
importance of this symptom. In this study we
found no diVerences in fatigue scores between
patients with primary SS and patients with RA,
both groups report significantly more fatigue
than healthy controls.
Fatigue is, among others, a symptom of
depression. In this study a subdivision could be
made between the more physical aspects
(physical fatigue and reduced activity) and the
more mental aspects (reduced motivation and
mental fatigue) of fatigue. Both patient groups
(primary SS and RA) scored high on the
depression questionnaire in comparison with
the healthy controls and in those patient groups
a correlation was found between depression
and all subscales of fatigue. In the patients with
primary SS, this correlation between depres-
sion and fatigue was statistically most signifi-
cant for the two mental scales of the fatigue
index.
By using depression as a covariate, the
analyses showed no diVerences in mental
fatigue and reduced motivation between the
three groups investigated, but after this correc-
tion for depression, significantly higher scores
were found in the two patient groups compared
with the healthy controls for the dimensions of
general fatigue, physical fatigue, and reduced
activity.
Moreover, in the RA patients a positive cor-
relation was found between the level of disease
activity and the physical aspects of fatigue
mentioned above. This concurs with previous
studies on fatigue in both RA and SLE in
which the disease activity of these patients also
correlated with the severity of the fatigue.2 23 24
In this study we found no clear relations
between the MFI scores and the laboratory
parameters used in the primary SS group.
These results are in line with a previous study
that found no association between ESR, Hb,
and the levels of antinuclear antibodies and
rheumatoid factors and tiredness in primary
SS.25 It may be hypothesised that in primary SS
aspects of fatigue are a better indicator of
disease activity than the laboratory parameters.
We did not analyse the sleeping patterns of our
patients; possibly sleep disturbances might
have contributed to the fatigue observed in our
patients.
A disturbance in the neuroendocrine system
as a cause of fatigue in primary SS has been
suggested.26 Although we observed no associa-
tion between the level of fatigue and blood
pressure measurements, a significant negative
correlation was found with plasma concentra-
tions of noradrenaline. Though there might be
influence of multiple testing, we think we
found a relation between general fatigue and
low noradrenaline values and this may point to
a link with subclinical disturbances of the
autonomic nervous system and fatigue.
In conclusion, fatigue is a serious problem in
patients with primary SS. Some aspects of
fatigue, such as mental fatigue and reduced
motivation can most probably be attributed to
depressive symptoms, but physical fatigue,
general fatigue, and reduced activity may be
related to disease activity in patients with
primary SS. Further studies to elucidate
whether specific aspects of fatigue may indeed
be used as one of the parameters of disease
activity in primary SS are warranted. The
negative correlation between plasma nor-
adrenaline values and the fatigue scores
suggests a possible autonomic dysfunction in
fatigued primary SS patients. Further studies
in larger patient populations are necessary to
elucidate this possible association.
1 Goldenberg DL. Fatigue in rheumatic disease. Bull Rheum
Dis 1995;44:4–8.
2 Belza BL. Comparison of self-reported fatigue in rheuma-
toid arthritis and controls. J Rheumatol 1995;22:639–43.
3 McCarthy DJ. Clinical picture of rheumatoid arthritis. In:
Mc Carthy DJ, Koopman WJ, eds. Arthritis and allied con-
ditions. Philadelphia: Lea and Febiger, 1993:788.
4 Crosby LJ. Factors which contribute to fatigue associated
with rheumatoid arthritis. J Adv Nurs 1991;16:974–81.
5 Moutsopoulos HM, Chused TH, Mann DL, Klippel JH,
Fauci AS, Frank MM. Sjögren’s syndrome (sicca
syndrome): current issues. Ann Intern Med 1980;92:212–
26.
6 Gudbjornsson B, Broman JE, Helta J, Hällgren R. Sleep
disturbances in patients with primary Sjögren’s syndrome.
B J Rheumatol 1993;32:1072–6.
7 Thomas PK. The chronic fatigue sndrome: what do we
know ? BMJ 1993;306:1557–8.
8 Pagani M, Lucini D, Mela GS, Langewitz W, Malliani A.
Sympathetic overactivity in subjects complaining of unex-
plained fatigue. Clin Sci 1994;87:655–61.
9 Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relation-
ship between neurally mediated hypotension and the
chronic fatigue syndrome. JAMA 1995;274:961–7.
10 Rowe PC, Bou-Holaigah I, Kan JS, Calkins H. Is neurally
mediated hypotension an unrecognised cause of chronic
fatigue? Lancet 1995;345:623–4.
11 Toussirot E, Serratrice G, Valentin P. Autonomic nervous
system involvement in rheumatoid artritis. 50 cases. J
Rheumatol 1993;20:1508–14.
12 Lioté F, Osterland CK. Autonomic neuropathy in systemic
lupus erythematosus: cardiovascular autonomic function
assessment. Ann Rheum Dis 1994;53:671–4.
13 Dessein PH, JoVe BI, Metz RM. Autonomic dysfunction in
systemic sclerosis: sympathetic overactivity and instability.
Am J Med 1992;93:143–50.
14 Andonopoulos AP, Ballas C. Autonomic cardiovascular
neuropathy in primary Sjögren’s syndrome. Rheumatol Int
1995;15:127–9.
15 Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G,
Bencivelli W, Bernstein R H. Preliminary criteria for the
classification of Sjogren’s syndrome. Arthritis Rheum
1993;36:340–7.
16 Chisholm DM, Mason DK. Labial salivary gland biopsy in
Sjögren’s disease. J Clin Pathol 1968;21:656–60.
17 Markusse HM, van Putten WIJ, Breedveld FC, Oudkerk M.
Digital subtraction sialography of the parotid glands in pri-
mary Sjogren’s syndrome. J Rheumatol 1993;20:279–83.
18 Arnett FC, Edworthy SM, Bloch DA. The American Rheu-
matism Association 1987 revised criteria for the classifica-
tion of rheumatoid arthritis. Arthritis Rheum 1988;31:
315–24.
294 Barendregt, Visser, Smets, et al
 on 11 December 2006 ard.bmj.comDownloaded from 
19 Smets EMA, Garsson B, Bonke N, de Haes JCJM. The
multidimensional fatigue inventory (MFI). Psychosomatic
qualities of an instrument to assess fatigue. J Psychosom
Res 1995;39:315–25.
20 Shumaker SA, Anderson RT,Czajkowski SM. Psychological
tests and scales. In: Spiker B, ed.Quality of life assessments in
clinical trials. New York: Raven Press, 1990:95–113.
21 Van der Hoorn FAJ, Boomsma F,Man in ‘t Veld AJ, Schale-
kamp MADH. Determination of plasmacatecholamines in
human plasma by high performance liquid
chromatography: comparison between a new method with
fluorescence detection and an established method with
electrochemical detection. J Chromatogr 1989;487:17–27.
22 vd Heyde DMFM, van ‘t Hof MA, van Riel PLCM. Judging
disease activity in clinical practice in rheumatoid arthritis:
first step in the development of a disease activity score. Ann
Rheum Dis 1990;49:916–20.
23 Krupp LB, La Rocca NG,Muir J, Steinbury AD. A study of
fatigue in systemic lupus erythematosus. J Rheumatol
1990;17:1450–2.
24 Wijsenbeek AJ, Leibovich L,Weinberger A,Guady D. Fatigue
in systemic lupus erythematosus, prevalence and relation to
disease expression. Br J Rheumatol 1993;32:633–5.
25 Jacobsson L, Kirtava Z, Olsson G, Axell T, Manthorpe R.
Tiredness in patients with primary Sjogren’s syndrome.
Clin Rheumatol 1995;14 (suppl 1):51.
26 Fox RI. Vth International Symposium on Sjogren’s
syndrome: clinical aspects and therapy. Clin Rheumatol
1995;14 (suppl 1):17–19.
Figure 1 Spina ventosa (tuberculous osteoperiostitis of the fingers).
Kirmission.Malattie degli arti. In: Duplay S, Reclus P, eds. Trattato di chirurgia. Turin:
Unione Tipografico Editrice, 1895.
Fatigue in primary Sjögren’s syndrome 295
 on 11 December 2006 ard.bmj.comDownloaded from 
